SAXAGLIPTIN
These highlights do not include all the information needed to use SAXAGLIPTIN TABLETS safely and effectively. See full prescribing information for SAXAGLIPTIN TABLETS. SAXAGLIPTIN tablets, for oral useInitial U.S. Approval: 2009
e286ffd4-c598-47fb-af06-2e15f7e6f99f
HUMAN PRESCRIPTION DRUG LABEL
Aug 1, 2023
Glenmark Pharmaceuticals Inc., USA
DUNS: 130597813
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
SAXAGLIPTIN
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (15)
SAXAGLIPTIN
Product Details
FDA regulatory identification and product classification information